Topical Drug Delivery Market

Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions), Liquids, Solids, Transdermal Products), Route (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), Facility of Use (Homecare, Hospital, Burn Center) - Global Forecast to 2024

Report Code: MD 5119 Aug, 2019, by marketsandmarkets.com

[188 Pages Report] The topical drug delivery market is projected to reach USD 123.2 billion by 2024 from USD 93.2 billion in 2019, at a CAGR of 5.7%. The high prevalence of skin & eye diseases, high incidence of burn injuries, and the growing prevalence of diabetes driving the demand for topical drug delivery. However, technical barriers related to skin irritation and permeability and drug failures and product recalls are the challenges associated with this market.

Topical Drug Delivery Market

The semi-solid formulations segment dominated the topical drug delivery market in 2018

By product, the market is segmented into semi-solid formulations (creams, gels, ointments, pastes, and lotions), solid formulations (suppositories and powders), liquid formulations (solutions and suspensions), and transdermal products (transdermal patches and transdermal semi-solids). The semi-solid formulations segment is expected to account the largest market share of the market in 2019. The advantages of semi-solid formulations such as faster drug release and greater patient acceptability topical gels, wide applications of topical pastes for the treatment and prevention of skin irritation, high spreadability and washability of creams for the treatment of various skin types are the factors driving the growth of this market.

Dermal drug delivery segment to account for the largest share of the topical drug delivery market, by route of administration, in 2018

The dermal drug delivery segment accounted for the largest share of the market in 2018. This is mainly due to the high prevalence of skin diseases across the globe. For instance, the prevalence of psoriasis worldwide ranges between 0.09% and 11.43%, making it a serious global problem with at least 100 million individuals affected worldwide. (Source: WHO 2016).

Homecare settings to account for the largest share of the market, by the facility of use, in 2018

Homecare settings accounted for the largest share of the market in 2018. Home care settings eliminate the need for patients to travel to healthcare facilities, thus saving time and money. Owing to this convenience and better affordability, an increasing number of patients are opting for home-based treatments, and these are some of the key factors driving the growth of this facility of use segment.  

Topical Drug Delivery Market

The North America market is expected to grow at the highest CAGR during the forecast period

North America dominated the market in 2018. Though, the North America region is expected to witness the highest CAGR during the forecast period. The rising prevalence of skin diseases, approvals, and launches of innovative topical formulations in the region, and funding for the development of topical drugs are some of the key factors driving the growth of this regional segment. For instance, in December 2018, Cipher Pharmaceuticals Inc. (Canada) received acceptance for its “A-101 40% topical solution” for review by Health Canada. This product is indicated for the treatment of raised seborrheic keratosis, which is a commonly occurring non-cancerous skin growth that affects more than 9 million Canadian adults. Similarly, in December 2018, GlaxoSmithKline (UK) invested USD 36.0 million in manufacturing sites in Canada to boost the production and support delivery of its leading topical pain reliever—VOLTAREN.

Key Market Players

Prominent players in the topical drug delivery market are Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), and Mylan (US).

Janssen Global Services is a subsidiary of Johnson & Johnson. Janssen provides medicines for a wide array of health concerns in several therapeutic areas, including ADHD, general medicine, mental health, neurology, pain management, and women’s health. The company sells its products through a network of distributors across the US. It operates through three business segments, namely, Pharmaceutical, Consumer, and Medical Devices. It offers topical products through its pharmaceutical and consumer segments.

Scope of the Report:

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Product, Route of Administration, Facility of use, and Region

Geographies covered

North America, Europe, the Asia Pacific, and the Rest of the World

Companies covered

Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), Glenmark Pharmaceuticals (India), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), GlaxoSmithKline (UK), Mylan (US), Hisamitsu Pharmaceutical (Japan), Crescita Therapeutics Inc. (Canada), and Cipla Ltd (India).

The research report categorizes the market into the following segments and sub-segments:

Topical drug delivery Market, by Product

  • Semi-solid Formulations
    • Creams
    • Ointments
    • Lotions
    • Gels
    • Pastes
  • Liquid Formulations
    • Suspensions
    • Solutions
  • Solid Formulations
    • Powders
    • Suppositories
  • Transdermal Products
    • Transdermal Patches
    • Transdermal Semi-solids

Topical drug delivery Market, by Route of Administration

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery
  • Nasal Drug Delivery

Topical drug delivery Market, by Facility of use

  • Homecare Settings
  • Hospitals & Clinics
  • Burn Centers
  • Other Facilities (academic & research institutes and diagnostic centers)

Topical Drug Delivery Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments

  • In April 2019, Crescita Therapeutics signed an out-licensing agreement with Cantabria labs for the sales and distribution of its topical Pliaglis formulation in Italy, Portugal, France, and Spain.
  • In November 2018, Bausch Healthcare expanded its manufacturing facility in Rochester (Ireland) to support and fulfill the demand of its topical eye health products.

Critical questions answered in the report:

  • How will the current technological trends affect the market in the long term?
  • What are the reasons contributing to the growth of the semi-solid market?
  • Which regions are likely to grow at the highest CAGR?
  • What are the challenges hindering the adoption of topical drug delivery devices?
  • What are the growth strategies being implemented by major market players?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 23)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
           2.2.3 Growth Forecast
    2.3 Market Data Validation and Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 35)
    4.1 Market Overview
    4.2 North America: Market, By Product, 2018
    4.3 Europe: Market, By Facility of Use, 2018
    4.4 Market: Geographic Snapshot

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence of Skin Diseases
                    5.2.1.2 Rising Prevalence of Eye Diseases
                    5.2.1.3 High Incidence of Burn Injuries
                    5.2.1.4 Growing Prevalence of Diabetes
           5.2.2 Restraints
                    5.2.2.1 Preference for Alternative Modes of Drug Delivery
           5.2.3 Opportunities
                    5.2.3.1 Delivery of Biologics Through the Transdermal Route
                    5.2.3.2 Self-Administration and Home Care
           5.2.4 Challenges
                    5.2.4.1 Technical Barriers Related to Skin Irritation and Permeability
                    5.2.4.2 Drug Failures and Product Recalls

6 Topical Drug Delivery Market, By Product (Page No. - 44)
    6.1 Introduction
    6.2 Semi-Solid Formulations
           6.2.1 Creams
                    6.2.1.1 Ease of Spreadability and Washability to Drive This Market Segment
           6.2.2 Ointments
                    6.2.2.1 Ointments are Widely Used in Analgesic Indications
           6.2.3 Lotions
                    6.2.3.1 Easy Administration of Lotions to Drive Their Demand Among End Users
           6.2.4 Gels
                    6.2.4.1 Faster Drug Release and Greater Patient Acceptability to Drive the Market for Topical Gels
           6.2.5 Pastes
                    6.2.5.1 Topical Pastes are Widely Used for the Treatment and Prevention of Skin Irritation
    6.3 Liquid Formulations
           6.3.1 Suspensions
                    6.3.1.1 Higher Rate of Bioavailability and Controlled Onset of Action to Support the Growth of the Topical Suspensions Market
           6.3.2 Solutions
                    6.3.2.1 Topical Solutions Comprise Soluble Chemicals That are Dissolved in Various Solvents
    6.4 Solid Formulations
           6.4.1 Powders
                    6.4.1.1 Powders have A Very Fine Particle Size That Covers A Large Surface Area Per Unit Weight
           6.4.2 Suppositories
                    6.4.2.1 Suppositories Require A Suitable Base That Ensures the Compatibility and Stability of the Drug
    6.5 Transdermal Products
           6.5.1 Transdermal Patches
                    6.5.1.1 Transdermal Patches to Account for the Largest Share of the Transdermal Drug Delivery Market in 2019
           6.5.2 Transdermal Semi-Solids
                    6.5.2.1 Transdermal Semi-Solids Segment to Witness Negative Growth During the Forecast Period

7 Topical Drug Delivery Market, By Route of Administration (Page No. - 65)
    7.1 Introduction
    7.2 Dermal Drug Delivery
           7.2.1 Dermal Drug Delivery is the Largest Segment in This Market Due to Advantages Such as Ease of Use and Increased Patient Compliance
    7.3 Ophthalmic Drug Delivery
           7.3.1 Increasing Use of Mobile Devices is Likely to Impact Vision, Which is A Key Factor Supporting Market Growth
    7.4 Rectal Drug Delivery
           7.4.1 Poor Absorption of Drugs Through the Rectal Route—A Key Disadvantage Associated With This Market Segment
    7.5 Vaginal Drug Delivery
           7.5.1 High Permeability of Vaginal Tissues, the Scope of Self-Administration, and Ease of Manufacturing are Expected to Boost the Growth of the Vaginal Drug Delivery Market Segment
    7.6 Nasal Drug Delivery
           7.6.1 Absence of Drug Degradation, High Efficacy of Nasally Administered Drugs, and Growing Preference for Self-Administration to Drive Market Growth

8 Topical Drug Delivery Market, By Facility of Use (Page No. - 72)
    8.1 Introduction
    8.2 Home Care Settings
           8.2.1 Home Care Settings Accounted for the Largest Share in 2018
    8.3 Hospitals and Clinics
           8.3.1 Rising Incidence of Surgical Site Infections to Drive This Segment
    8.4 Burn Centers
           8.4.1 High Incidence of Burn Injuries Across the Globe to Support the Market Growth
    8.5 Other Facilities

9 Topical Drug Delivery Market, By Region (Page No. - 78)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 Rising Prevalence of Skin Diseases and the Approval and Launch of Innovative Topical Formulations—Key Factors Driving Market Growth
           9.2.2 Canada
                    9.2.2.1 Rising Prevalence of Skin Diseases and Funding for the Development of Topical Drugs to Drive Market Growth
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Growing Focus of Pharmaceutical Companies on the Development of Topical Products to Drive Market Growth
           9.3.2 UK
                    9.3.2.1 Rising Prevalence of Skin Diseases & Chronic Conditions to Drive Market Growth
           9.3.3 France
                    9.3.3.1 Rising Prevalence of Skin Diseases and Development of Topical Drugs By Local Players to Support Market Growth
           9.3.4 Rest of Europe
    9.4 Asia Pacific
           9.4.1 Japan
                    9.4.1.1 Increasing Number of Product Approvals and Growing Focus of Local Players on the R&D of Topical Formulations to Support Market Growth
           9.4.2 China
                    9.4.2.1 Growing Focus of Major Players in China on the Development of Topical Drugs to Drive Market Growth
           9.4.3 India
                    9.4.3.1 Rising Awareness Among Healthcare Providers & Patients and Increasing Focus on Noninvasive Methods of Drug Delivery to Drive Market Growth
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 145)
     10.1 Overview
     10.2 Market Share Analysis
             10.2.1 Johnson & Johnson
             10.2.2 Nestlι Sa (Galderma)
             10.2.3 Novartis
     10.3 Competitive Scenario
             10.3.1 Product Launches
             10.3.2 Expansions
             10.3.3 Agreements and Collaborations
             10.3.4 Acquisitions
     10.4 Competitive Leadership Mapping (Overall Market) (2018)
             10.4.1 Visionary Leaders
             10.4.2 Innovators
             10.4.3 Dynamic Differentiators
             10.4.4 Emerging Companies

11 Company Profiles (Page No. - 150)
(Business Overview, Products Offered, Recent Developments, MnM View
     11.1 Glaxosmithkline
     11.2 Janssen Global Services (A Subsidiary of Johnson & Johnson)
     11.3 Bausch Health Companies
     11.4 Merck & Co.
     11.5 Bayer AG
     11.6 Hisamitsu Pharmaceutical
     11.7 Nestlι Sa
     11.8 Novartis AG
     11.9 Glenmark Pharmaceuticals
     11.10 Cipla
     11.11 Crescita Therapeutics Inc.
     11.12 Mylan N.V.

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 182)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Related Reports
     12.4 Author Details


List of Tables (143 Figures)

Table 1 Topical Drug Delivery Market, By Product, 2017–2024 (USD Million)
Table 2 Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 3 Market for Semi-Solid Formulations, By Country, 2017–2024 (USD Million)
Table 4 Market for Creams, By Country, 2017–2024 (USD Million)
Table 5 Market for Ointments, By Country, 2017–2024 (USD Million)
Table 6 Market for Lotions, By Country, 2017–2024 (USD Million)
Table 7 Market for Gels, By Country, 2017–2024 (USD Million)
Table 8 Market for Pastes, By Country, 2017–2024 (USD Million)
Table 9 Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 10 Market for Liquid Formulations, By Country, 2017–2024 (USD Million)
Table 11 Market for Suspensions, By Country, 2017–2024 (USD Million)
Table 12 Market for Solutions, By Country, 2017–2024 (USD Million)
Table 13 Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 14 Market for Solid Formulations, By Country, 2017–2024 (USD Million)
Table 15 Topical Drug Delivery Market for Powders, By Country, 2017–2024 (USD Million)
Table 16 Market for Suppositories, By Country, 2017–2024 (USD Million)
Table 17 Comparison Between Transdermal Patches and Transdermal Semi-Solid Formulations
Table 18 Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 19 Market for Transdermal Products, By Country, 2017–2024 (USD Million)
Table 20 Market for Transdermal Patches, By Country, 2017–2024 (USD Million)
Table 21 Market for Transdermal Semi-Solids, By Country, 2017–2024 (USD Million)
Table 22 Topical Drug Delivery Market, By Route of Administration, 2017–2024 (USD Million)
Table 23 Dermal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 24 Ophthalmic Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 25 Rectal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 26 Vaginal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 27 Nasal Drug Delivery Market, By Country, 2017–2024 (USD Million)
Table 28 Market, By Facility of Use, 2017–2024 (USD Million)
Table 29 Topical Drug Delivery Market for Home Care Settings, By Country, 2017–2024 (USD Million)
Table 30 Market for Hospitals & Clinics, By Country, 2017–2024 (USD Million)
Table 31 Market for Burn Centers, By Country, 2017–2024 (USD Million)
Table 32 Market for Other Facilities, By Country, 2017–2024 (USD Million)
Table 33 Market, By Country, 2017–2024 (USD Million)
Table 34 North America: Market, By Country, 2017–2024 (USD Million)
Table 35 North America: Market, By Route of Administration, 2017–2024 (USD Million)
Table 36 North America: Market, By Product, 2017–2024 (USD Million)
Table 37 North America: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 38 North America: Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 39 North America: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 40 North America: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 41 North America: Market, By Facility of Use, 2017–2024 (USD Million)
Table 42 Product Approvals & Launches in the US Market (2017–2019)
Table 43 US: Market, By Route of Administration, 2017–2024 (USD Million)
Table 44 US: Market, By Product, 2017–2024 (USD Million)
Table 45 US: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 46 US: Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 47 US: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 48 US: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 49 US: Market, By Facility of Use, 2017–2024 (USD Million)
Table 50 Canada: Market, By Route of Administration, 2017–2024 (USD Million)
Table 51 Canada: Market, By Product, 2017–2024 (USD Million)
Table 52 Canada: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 53 Canada: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 54 Canada: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 55 Canada: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 56 Canada: Market, By Facility of Use, 2017–2024 (USD Million)
Table 57 Recent Developments in the European Topical Drug Delivery Market, 2015–2018
Table 58 Europe: Market, By Country, 2017–2024 (USD Million)
Table 59 Europe: Market, By Route of Administration, 2017–2024 (USD Million)
Table 60 Europe: Market, By Product, 2017–2024 (USD Million)
Table 61 Europe: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 62 Europe: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 63 Europe: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 64 Europe: Topical Drug Delivery Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 65 Europe: Market, By Facility of Use, 2017–2024 (USD Million)
Table 66 Developments in the Field of Topical Drug Delivery in Germany, 2017–2019
Table 67 Germany: Market, By Route of Administration, 2017–2024 (USD Million)
Table 68 Germany: Market, By Product, 2017–2024 (USD Million)
Table 69 Germany: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 70 Germany: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 71 Germany: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 72 Germany: Topical Drug Delivery Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 73 Germany: Market, By Facility of Use, 2017–2024 (USD Million)
Table 74 Developments in the Market in the Uk, 2016–2019
Table 75 UK: Market, By Route of Administration, 2017–2024 (USD Million)
Table 76 UK: Market, By Product, 2017–2024 (USD Million)
Table 77 UK: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 78 UK: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 79 UK: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 80 UK: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 81 UK: Topical Drug Delivery Market, By Facility of Use, 2017–2024 (USD Million)
Table 82 France: Market, By Route of Administration, 2017–2024 (USD Million)
Table 83 France: Market, By Product, 2017–2024 (USD Million)
Table 84 France: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 85 France: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 86 France: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 87 France: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 88 France: Market, By Facility of Use, 2017–2024 (USD Million)
Table 89 RoE: Market, By Route of Administration, 2017–2024 (USD Million)
Table 90 RoE: Topical Drug Delivery Market, By Product, 2017–2024 (USD Million)
Table 91 RoE: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 92 RoE: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 93 RoE: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 94 RoE: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 95 RoE: Market, By Facility of Use, 2017–2024 (USD Million)
Table 96 Developments in the Topical Drug Delivery Market in the Asia Pacific, 2016–2019
Table 97 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 98 Asia Pacific: Market, By Route of Administration, 2017–2024 (USD Million)
Table 99 Asia Pacific: Market, By Product, 2017–2024 (USD Million)
Table 100 Asia Pacific: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 101 Asia Pacific: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 102 Asia Pacific: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 103 Asia Pacific: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 104 Asia Pacific: Market, By Facility of Use, 2017–2024 (USD Million)
Table 105 Japan: Market, By Route of Administration, 2017–2024 (USD Million)
Table 106 Japan: Topical Drug Delivery Market, By Product, 2017–2024 (USD Million)
Table 107 Japan: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 108 Japan: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 109 Japan: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 110 Japan: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 111 Japan: Market, By Facility of Use, 2017–2024 (USD Million)
Table 112 China: Market, By Route of Administration, 2017–2024 (USD Million)
Table 113 China: Market, By Product, 2017–2024 (USD Million)
Table 114 China: Topical Drug Delivery Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 115 China: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 116 China: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 117 China: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 118 China: Market, By Facility of Use, 2017–2024 (USD Million)
Table 119 India: Market, By Route of Administration, 2017–2024 (USD Million)
Table 120 India: Market, By Product, 2017–2024 (USD Million)
Table 121 India: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 122 India: Topical Drug Delivery Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 123 India: Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 124 India: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 125 India: Market, By Facility of Use, 2017–2024 (USD Million)
Table 126 RoAPAC: Market, By Route of Administration, 2017–2024 (USD Million)
Table 127 RoAPAC: Market, By Product, 2017–2024 (USD Million)
Table 128 RoAPAC: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 129 RoAPAC: Market for Liquid Formulations, By Type, 2017–2024 (USD Million)
Table 130 RoAPAC: Topical Drug Delivery Market for Solid Formulations, By Type, 2017–2024 (USD Million)
Table 131 RoAPAC: Market for Transdermal Products, By Type, 2017–2024 (USD Million)
Table 132 RoAPAC: Market, By Facility of Use, 2017–2024 (USD Million)
Table 133 RoW: Market, By Route of Administration, 2017–2024 (USD Million)
Table 134 RoW: Market, By Product, 2017–2024 (USD Million)
Table 135 RoW: Market for Semi-Solid Formulations, By Type, 2017–2024 (USD Million)
Table 136 RoW: Topical Drug Delivery Market for Liquid Formulations Market, By Type, 2017–2024 (USD Million)
Table 137 RoW: Market for Solid Formulations Market, By Type, 2017–2024 (USD Million)
Table 138 RoW: Market for Transdermal Products Market, By Type, 2017–2024 (USD Million)
Table 139 RoW: Market, By Facility of Use, 2017–2024 (USD Million)
Table 140 Product Launches
Table 141 Expansions
Table 142 Agreements and Collaborations
Table 143 Acquisitions


List of Figures (38 Figures)

Figure 1 Topical Drug Delivery Market Segmentation
Figure 2 Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Market Share, By Product, 2018
Figure 9 Topical Drug Delivery Market Share, By Route of Administration, 2018
Figure 10 Market Share, By Facility of Use, 2018
Figure 11 Geographic Snapshot: Market, 2018
Figure 12 High Prevalence of Skin Diseases and High Incidence of Burn Injuries to Drive the Growth of the Market
Figure 13 Semi-Solid Formulations to Dominate the North American Market During the Forecast Period
Figure 14 Home Care Settings to Dominate the European Market During the Forecast Period
Figure 15 US to Grow at the Highest CAGR During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Semi-Solid Formulations Segment to Command the Largest Share of the Market in 2019
Figure 18 Dermal Drug Delivery to Dominate the Market During the Forecast Period
Figure 19 Home Care Settings Segment to Command the Largest Share of the Market in 2019
Figure 20 Market, By Region, 2019 vs 2024
Figure 21 North America: Topical Drug Delivery Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia Pacific: Market Snapshot
Figure 24 Rest of the World: Market Snapshot
Figure 25 Market Share Analysis By Key Players (2018)
Figure 26 Topical Drug Delivery Market (Global) Competitive Leadership Mapping, 2018
Figure 27 Glaxosmithkline PLC: Company Snapshot
Figure 28 Johnson & Johnson: Company Snapshot
Figure 29 Bausch Health Companies: Company Snapshot
Figure 30 Merck & Co.: Company Snapshot
Figure 31 Bayer AG.: Company Snapshot
Figure 32 Hisamitsu Pharmaceutical: Company Snapshot
Figure 33 Nestlι SA: Company Snapshot
Figure 34 Novartis AG: Company Snapshot
Figure 35 Glenmark Pharmaceuticals: Company Snapshot
Figure 36 Cipla: Company Snapshot
Figure 37 Crescita Therapeutics: Company Snapshot (2018)
Figure 38 Mylan: Company Snapshot (2018)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the topical drug delivery market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the topical drug delivery market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from medical devices companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Topical Drug Delivery Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, route of administration, facility of use, and region).

Data Triangulation

After arriving at the market size, the market was divided into several segments and sub-segments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & sub-segments.

Objectives of the Study

  • To define, describe, segment, and forecast the global topical drug delivery market by product, route of administration, facility of use, and region.
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in four main regions along with their respective key countries (North America, Europe, the Asia Pacific, and the Rest of the World)
  • To profile key players in the global market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as product launches and expansions; and R&D activities of the leading players in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • A further breakdown of the Rest of Asia Pacific market into South Korea, New Zealand, and other Southeast Asian countries
  • A further breakdown of the European market into Spain, Belgium, Netherlands, Sweden, and the Rest of Europe.
Report Code
MD 5119
Published ON
Aug, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Topical Drug Delivery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home